摘要:
The use of malachite green in the form of a tetramethyldiamino-triphenyl-carbinol anhydro-oxalate [(C23H25N2)—(C2HO4)]2—C2H2O4 of the following structural formula as a drug for treating malignant neoplasms administered in a single doze of 1 to 2 g. Malachite green can be used when dissolved in an aqueous solution or in a physiological salt solution or in spirit. In different cases, the malachite green solution is perorally administered before and after a meal or is injected per rectum, or a 1% malachite green solution is intravenously introduced, or the malachite green is applied as a rectal suppository component or as a component of 1-5% ointment. The medicinal agent exhibits an extended range of therapeutic actions with respect to different oncological diseases, is freely available, not expensive, non-toxic, does not generate side effects when used in pharmaceutically acceptable doses, and makes it possible to reduce a treating time and to increase the efficiency of treatment.
摘要:
Biology and medicine for cleaning biological fluids. A system for correcting a biological fluid includes a sealed container for a magnetically operated absorbent (MOA), a sealed chamber for mixing the absorbent with a biological fluid and for the absorbent precipitation therefrom, and a sealed filtering unit. The chamber and container are embodied so that they can modify the volumes thereof, have a common interchamber partition-wall fixed to the bottom and are interconnected through a passage embodied in the wall. The other sidewalls of the chambers have corrugations which form bellows. Lids of the chambers are pivotally connected so that they are pivotable around the pivot axis. The MOA container is arranged inside the absorber-mixing chamber and embodied as a bellow. An inlet connection is simultaneously connected to the inside cavities of the absorber-mixing chamber and to the container thereof.
摘要:
An organic dye from the group of crystal violet, gentian violet, malachite green oxalate and rhodamine 6G used as an analgesic agent in the form of a solution with the agent dosage ranging from 0.000001 mg to 10 g per intake. It is preferable to take the agent at least two times a day. In particular cases of use the agent is administered by mouth in the form of an aqueous solution before or after meals, or it is administered per rectum in the form of an aqueous solution, or a 1% solution of the agent is administered intravenously, or the agent is used in the form of a 1-5% ointment, or the agent is administered per rectum in the form of suppositories, and when arresting cancer pain the agent is injected into the tumor (under the tumor) or into a metastasis. Herein, one uses as analgesic agents widely available and inexpensive substances that are non-toxic, have no allergic effects and cause no addiction (dependence) when used in pharmaceutically acceptable doses; the treatment time is reduced, treatment efficiency is enhanced, and pain relief is provided while preserving patients' functional activity, using the minimum arsenal of analgesic agents with different effects, and completely eliminating the need for opiates.
摘要:
An absorbent includes a ferromagnetic nucleus with a one-layer or two-layer shell or devoid thereof and the nucleus is embodied in the form of a plate with a planar size that ranges from 500-5000 μm and the thickness is equal to 0.1-1000 μm. The method for producing the inventive magnetically-operated absorbent includes evaporating and/or melting a magnetic material powder in a low-temperature plasma, quenching and condensing the thus obtained vaporized and/or melt-particle product in a gas flux, and transferring the product precipitated in the form of crystals or micro slugs of corresponding metals, correspondingly to a stabilizer-containing dispersion medium and holding in the medium until a gas release is over. Then the crystals or micro slugs are processed by flatting, for example pressing so that the plates of a specified thickness are obtained.
摘要:
Medicine, in particular broad spectrum medicinal preparations. This invention is based on the use of 4-chlorine-2-methyl-phenoxy-acetic acid of formula I, the pharmacologically acceptable derivatives thereof, for example on corresponding alkali metal salts of the acid and the derivatives in the form of pharmaceutical preparations exhibiting immunomodulating, anti-inflammatory and anti-tumoral properties and antiviral activity. The broad spectrum of therapeutic modalities of the inventive medicinal preparation and the fact that it does not produce side effects are proven by study.
摘要:
Biology and medicine that can be used for cleaning biological fluids and for bringing the content to meet physiological standards. An absorbent includes a ferromagnetic nucleus with a one-layer or two-layer shell or devoid thereof and the nucleus is embodied in the form of a plate with a planar size that ranges from 500-5000 □m and the thickness is equal to 0.1-1000 □m. The method for producing the inventive magnetically-operated absorbent includes evaporating and/or melting a magnetic material powder in a low-temperature plasma, quenching and condensing the thus obtained vaporized and/or melt-particle product in a gas flux, and transferring the product precipitated in the form of crystals or micro slugs of corresponding metals, correspondingly to a stabilizer-containing dispersion medium and holding in the medium until a gas release is over. Then the crystals or micro slugs are processed by flatting, for example pressing so that the plates of a specified thickness are obtained. The plates are repeatedly (up to 10 times) washed with distilled water, the weak sections thereof are separated by exposing them in water, for example to the action of ultrasound with power ranges, for example from 200 to 300 W/cm2, and the thus produced plates are dried. The dried plates are broken up, the absorbent nucleuses of a required size are obtained and the shells are formed thereon layer-by-layer. The final product is packed in light-protected sealed containers and sterilized, for example by γ-radiation. The final product can be also selected in the form of an absorbent produced immediately after the fractionation thereof.
摘要:
The use of malachite green in the form of a tetramethyldiamino-triphenyl-carbinol anhydro-oxalate [(C23H25N2)—(C2HO4)]2—C2H2O4 of the following structural formula as a drug for treating malignant neoplasms administered in a single dose of 1 to 2 g. Malachite green can be used when dissolved in an aqueous solution or in a physiological salt solution or in spirit. In different cases, the malachite green solution is perorally administered before and after a meal or is injected per rectum, or a 1% malachite green solution is intravenously introduced, or the malachite green is applied as a rectal suppository component or as a component of 1-5% ointment. The medicinal agent exhibits an extended range of therapeutic actions with respect to different oncological diseases, is freely available, not expensive, non-toxic, does not generate side effects when used in pharmaceutically acceptable doses, and makes it possible to reduce a treating time and to increase the efficiency of treatment.
摘要:
An absorbent includes a ferromagnetic nucleus with a one-layer or two-layer shell or devoid thereof and the nucleus is embodied in the form of a plate with a planar size that ranges from 500-5000 μm and the thickness is equal to 0.1-1000 μm. The method for producing the inventive magnetically-operated absorbent includes evaporating and/or melting a magnetic material powder in a low-temperature plasma, quenching and condensing the thus obtained vaporized and/or melt-particle product in a gas flux, and transferring the product precipitated in the form of crystals or micro slugs of corresponding metals, correspondingly to a stabilizer-containing dispersion medium and holding in the medium until a gas release is over. Then the crystals or micro slugs are processed by flattening, for example pressing so that the plates of a specified thickness are obtained.
摘要:
Medicine and pharmacology, in particular a medicinal agent exhibiting anti-tumoral and immunomodulatory actions and including a tri-p-amino-thiphenyl-chlormethan tetramethylated, pentamethylated or hexamethylated derivative, the mixtures thereof or the combination thereof with dextrin. The agent of this invention exhibits a high activity and a reduced side effect.